The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWatkin Jones Regulatory News (WJG)

Share Price Information for Watkin Jones (WJG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.95
Bid: 50.10
Ask: 50.30
Change: 1.10 (2.25%)
Spread: 0.20 (0.399%)
Open: 49.00
High: 50.30
Low: 49.00
Prev. Close: 48.85
WJG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

15 May 2023 10:45

RNS Number : 4241Z
Watkin Jones plc
15 May 2023
 

For immediate release

15 May 2023

 

Watkin Jones plc

('Watkin Jones' or the 'Company')

 

Issue of Equity

 

Watkin Jones plc (AIM: WJG) announces that it has issued and allotted 10,886 ordinary shares of 1 penny each in the Company ('Ordinary Shares') pursuant to the exercise of awards under the Company's Long Term Incentive Plan ('LTIP').

 

Accordingly, application has been made for the 10,886 new Ordinary Shares to be admitted to trading on AIM ('Admission'). It is expected that Admission will become effective, and that dealings will commence in the new Ordinary Shares at 8am (BST) on 16 May 2023. The new Ordinary Shares will rank, pari passu, with the existing Ordinary Shares.

 

Total Voting Rights

 

Following Admission, the Company's total issued share capital will comprise 256,441,253 Ordinary Shares. The Company does not hold any shares in treasury. Therefore, the total number of voting rights in the Company will be 256,441,253. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change of interest in, the share capital of the Company under the FCA's Disclosure, Guidance and Transparency Rules.

 

- Ends -

 

For further information:

Watkin Jones plc

 

Richard Simpson, Chief Executive Officer

Tel: +44 (0) 20 3617 4453

Sarah Sergeant, Chief Financial Officer

www.watkinjonesplc.com

 

Peel Hunt LLP (Nominated Adviser & Joint Corporate Broker)

 

Tel: +44 (0) 20 7418 8900

Mike Bell / Ed Allsopp

www.peelhunt.com

 

Jefferies Hoare Govett (Joint Corporate Broker)

 

Tel: +44 (0) 20 7029 8000

James Umbers / David Sheehan / Paul Bundred

 

www.jefferies.com

 

Media enquiries:

Buchanan

 

Henry Harrison-Topham / Jamie Hooper

Tel: +44 (0) 20 7466 5000

watkinjones@buchanan.uk.com

www.buchanan.uk.com

 

 

Notes to Editors

Watkin Jones is the UK's leading developer and manager of residential for rent, with a focus on the build to rent, student accommodation and affordable housing sectors. The Group has strong relationships with institutional investors, and a reputation for successful, on-time-delivery of high quality developments. Since 1999, Watkin Jones has delivered 48,000 student beds across 143 sites, making it a key player and leader in the UK purpose-built student accommodation market, and is increasingly expanding its operations into the build to rent sector. In addition, Fresh, the Group's specialist accommodation management business, manages over 22,000 student beds and build to rent apartments on behalf of its institutional clients. Watkin Jones has also been responsible for over 80 residential developments, ranging from starter homes to executive housing and apartments.

 

The Group's competitive advantage lies in its experienced management team and capital-light business model, which enables it to offer an end-to-end solution for investors, delivered entirely in-house with minimal reliance on third parties, across the entire life cycle of an asset.

 

Watkin Jones was admitted to trading on AIM in March 2016 with the ticker WJG.L. For additional information please visit www.watkinjonesplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEUVOKROKUVARR
Date   Source Headline
18th Jan 20177:00 amRNSFull Year Results 2016
22nd Dec 20167:00 amRNSUpdate on Developments
1st Dec 20167:00 amRNSCardiff and Belfast developments forward sold
17th Nov 20167:00 amRNSPre-Close Trading Statement
4th Oct 20167:00 amRNSForward Sale of St. Mungo Avenue, Glasgow
27th Sep 20167:00 amRNSUpdate on developments completed in 2016
22nd Sep 20167:00 amRNSPlanning consent granted for Hunter Street,Chester
13th Sep 20167:00 amRNSPlanning consent granted for site in Newcastle
22nd Jul 201612:45 pmRNSNotification of Major Interest in Shares
11th Jul 20163:15 pmRNSHoldings in Company
29th Jun 20167:00 amRNSPlanning consent granted for Duncan House
27th Jun 20167:00 amRNSDirector Dealing
9th Jun 20167:00 amRNSHalf year results
20th Apr 20167:00 amRNSIssue of Shares
7th Apr 20167:00 amRNSPre-Close Trading Statement
24th Mar 20169:15 amRNSIssue of Shares
23rd Mar 20167:00 amRNSFirst Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.